J.P. Morgan and RBC analysts are expecting updates on several key markets on Medtronic’s Q4 call, including surgical robotics and pulsed field ablation.
J.P. Morgan and RBC analysts are expecting updates on several key markets on Medtronic’s Q4 call, including surgical robotics and pulsed field ablation.